Furthermore, while E.G7 cancer cells promoted the activation of peptide-specific CD8+ T cells, SMG exposure of the E.G7 targets significantly increased both T cell-mediated IFN-γ production and tumor cell lysis. The gene discussed is CD8A; the disease is neoplasm.